obesity drugs glp-1 news today Market Overview: GLP-1 Agonists and the Obesity Market | Blog

The current range of weight-loss drugs on the market targets GLP-1 receptors. Seeking a new generation of weight-loss drugs, some companies are developing amylin analogs. Read more: https://brnw.ch/21x1oec

22.24

★★★★☆4.8 (126)

Game changing' data: New obesity drugs tied to major weight loss, may reduce CV risk

29.64

★★★★★4.9 (98)

GLP-1 Agonists Weight Loss Drugs Market Size Report, 2030

25.63

★★★★★5.0 (157)

The FDA approved a new GLP-1 pill for weight loss from Eli Lilly on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' @DrLaPook has more on the new medication

23.33

★★★★★4.7 (84)

Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans: Cell Reports Medicine

26.48

★★★★★4.9 (203)

What is the pipeline for future medications for obesity?

24.07

★★★★★5.0 (176)

Skyrocketing Cost of Obesity Drugs Has State Medicaid Programs Looking for Solutions

27.60

★★★★★4.8 (132)